VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) AND MELANOMA. N-ACETYLCYSTEINE DOWNREGULATES VEGF PRODUCTION IN VITRO
- 1 April 2000
- Vol. 12 (4) , 374-378
- https://doi.org/10.1006/cyto.1999.0566
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cellsPublished by Elsevier ,2004
- Halting angiogenesis suppresses carcinoma cell invasionNature Medicine, 1997
- Enhanced expression of vascular endothelial growth factor in metastatic melanomaBritish Journal of Cancer, 1997
- Angiogenesis and malignant melanoma. Angiogenesis is related to the development of vertical (tumorigenic) growth phaseJournal of Cutaneous Pathology, 1997
- Vascular permeability factor (VPF, VEGF) in tumor biologyCancer and Metastasis Reviews, 1993
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990
- Vascular Permeability Factor, an Endothelial Cell Mitogen Related to PDGFScience, 1989
- Vascular Endothelial Growth Factor Is a Secreted Angiogenic MitogenScience, 1989
- Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis.Journal of Clinical Investigation, 1989
- Effect of N-acetylcysteine on plasma cysteine and glutathione following paracetamol administrationEuropean Journal of Clinical Pharmacology, 1989